ROBERTO CARMONA: Open Payments
NPI 1538563838 · PEMBROKE PINES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 22 payments from 8 companies in 2025. Trend: 2023 $123 · 2024 $399 · 2025 $570
Food & beverage: $570
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $156 |
| Neurocrine BioSciences, Inc. | 2 | $72 |
| Janssen Pharmaceuticals, Inc | 3 | $69 |
| E.R. Squibb & Sons, L.L.C. | 3 | $66 |
| Alkermes, Inc. | 2 | $62 |
| Corium, LLC | 2 | $56 |
| ABBVIE INC. | 2 | $49 |
| Indivior Inc. | 1 | $42 |
Products named: CAPLYTA, INGREZZA, SPRAVATO, COBENFY, VIVITROL, Azstarys, VRAYLAR, SUBLOCADE.
Industry payments across FL — which companies pay providers there.
